Novogene

Novogene

A company that is a provider of genomic services with NGS and bioinformatics. It was founded in 2011 and is headquartered in Beijing, China with offices in Hong Kong, the United States, and the United Kingdom.

Novogene is a Beijing-based biotechnology company with 2,600 employees. It owns 22 NGS-related patents, and has published over 4,920 customer research papers.Company founder, Dr. Ruiqiang Li, is best known for developing the software SOAP (Short Oligonucleotide Analysis Package) for sequence mapping, variation detection, and de novo genome assembly.

Product

Novogene is an Illumina Genome Network partner. They offer a range of NGS-based services for human, plant, animal and microbial DNA and RNA analysis.Services offered include human genome sequencing, gene regulation, single-cell sequencing, animal and plant solutions (such as genome sequencing), and microbial genome sequencing. Pharmaceutical companies can also utilize Novogene's technology for drug development related to insights gained from genomic sequencing. The technology at the company uses various systems, such as HiSeq X, to sequence genomes, which allows for the company to annually sequence 280,000 human genomes.

Funding

In its series B round of funding in 2016, Novogene raised $75 million.

Timeline

2011

Novogene was founded.

People

Name
Role
LinkedIn

Dr. Ruiqiang Li

Founder

Further reading

Title
Author
Link
Type
Date

New Products Posted to GenomeWeb: ChunLab, Streck, Novogene

Web

August 9, 2019

Documentaries, videos and podcasts

Title
Date
Link

Leading Edge Genomic Services & Solutions

March 28, 2019

Companies

Company
CEO
Location
Products/Services

News

Title
Author
Date
Publisher
Description
July 10, 2019
WebWire
Mission Bio, the pioneer in targeted single-cell DNA analysis and precision genomics, today announced that it has launched sales in China through a distribution agreement with Novogene, a leading provider of genomic services and solutions globally. The deal brings the Mission Bio Tapestri® Platform to the rapidly expanding Chinese market. China is one of the world's largest next-generation sequencing (NGS) markets, with enormous opportunities for genomics. Thanks to greater investment i...

References

Golden logo
Text is available under the Creative Commons Attribution-ShareAlike 4.0; additional terms apply. By using this site, you agree to our Terms & Conditions.